pacific
biosciences
launches
sequel
iie
system
accelerate
adoption
highly
accurate
hifi
sequencing
nasdaq
pacb
menlo
park
globe
newswire
pacific
biosciences
california
nasdaq
pacb
leading
provider
sequencing
genomes
transcriptomes
epigenomes
today
announced
launch
iie
system
next
instrument
evolution
based
company
single
molecule
sequencing
technology
increased
computational
capacity
data
processing
new
system
directly
produce
highly
accurate
long
reads
hifi
reads
quickly
ever
providing
scientists
comprehensive
view
genomes
transcriptomes
new
sequel
iie
system
represents
next
advance
technology
makes
hifi
sequencing
accessible
project
high
accuracy
long
read
lengths
affordability
matter
said
christian
henry
chief
executive
officer
pacific
biosciences
prior
hifi
sequencing
researchers
used
multiple
technologies
complex
analysis
methods
order
obtain
results
comparable
hifi
data
sequel
iie
system
simple
produce
hifi
data
directly
scientists
feel
confident
using
one
technology
power
genetic
based
reliability
performance
sequel
ii
system
sequel
iie
system
features
hardware
software
improvements
enable
users
work
directly
valuable
informative
sequencing
data
currently
available
pacbio
hifi
reads
optimized
hifi
sequencing
sequel
iie
system
eliminates
need
sequence
data
users
delivers
reduction
overall
secondary
analysis
time
depending
application
addition
new
capability
provides
much
reduction
file
transfer
data
storage
needs
release
includes
powerful
new
tools
smrt
link
software
enable
complete
workflow
integration
aws
cloud
new
genome
assembly
analysis
application
generating
de
novo
assemblies
hifi
reads
hifi
reads
allow
accurate
simultaneous
detection
single
nucleotide
structural
variants
paving
way
advancements
human
genetics
greatly
expanding
utility
smrt
sequencing
said
fritz
sedlazeck
phd
assistant
professor
human
genome
sequencing
center
baylor
college
medicine
generating
hifi
reads
directly
sequel
iie
system
potential
accelerate
access
sequencing
pacbio
hifi
reads
combine
accuracy
sanger
sequencing
long
reads
kb
together
length
accuracy
hifi
reads
make
ideal
de
novo
genome
assembly
detection
variants
single
nucleotide
large
structural
variants
genomic
transcriptomic
investigations
hifi
sequencing
provided
important
data
number
global
research
projects
including
consortium
darwin
tree
life
human
pangenome
reference
consortium
project
among
others
precisionfda
truth
challenge
evaluated
methods
variant
calling
human
genomes
highlighted
approaches
use
pacbio
hifi
reads
delivered
highest
precision
recall
categories
including
specifically
regions
major
histocompatibility
complex
additional
details
sequel
iie
system
hifi
sequencing
applications
presented
ancillary
workshop
monday
october
pdt
american
society
human
genetics
ashg
annual
meeting
free
virtual
event
registration
available
pacbio
currently
accepting
orders
sequel
iie
system
new
instrument
delivery
expected
begin
quarter
additionally
sequel
ii
system
customers
able
purchase
instrument
upgrade
package
give
functionality
sequel
iie
system
information
sequel
iie
system
please
visit
sequel
pacific
biosciences
pacific
biosciences
california
nasdaq
pacb
empowering
life
scientists
highly
accurate
sequencing
company
innovative
instruments
based
single
molecule
sequencing
technology
delivers
comprehensive
view
genomes
transcriptomes
epigenomes
enabling
access
full
spectrum
genetic
variation
organism
cited
thousands
publications
sequencing
systems
use
scientists
around
world
drive
discovery
human
biomedical
research
plant
animal
sciences
microbiology
information
please
visit
follow
pacbio
pacbio
products
provided
research
use
use
diagnostic
procedures
statements
statements
press
release
historical
statements
including
among
things
statements
relating
future
availability
uses
accuracy
quality
affordability
capability
reliability
performance
benefits
using
products
technologies
including
smrt
sequencing
sequel
iie
system
suitability
utility
methods
products
technologies
particular
applications
projects
expected
benefits
insights
gained
research
teams
using
products
technologies
future
events
place
undue
reliance
statements
involve
known
unknown
risks
uncertainties
changes
circumstances
factors
cases
beyond
pacific
biosciences
control
could
cause
actual
results
differ
materially
information
expressed
implied
statements
made
press
release
factors
could
materially
affect
actual
results
found
pacific
biosciences
recent
filings
securities
exchange
commission
including
pacific
biosciences
recent
reports
forms
include
listed
caption
risk
pacific
biosciences
undertakes
obligation
revise
update
information
press
release
reflect
events
circumstances
future
even
new
information
becomes
available
contacts
media
colin
sanford
colin
investors
trevin
rard
ir
photo
accompanying
announcement
available
https
newsroom
attachmentng
